Intragastric balloon in obese patients

Area of Science:

• Bariatric surgery
• Obesity management
• Gastroenterology

Background:

• The BioEnterics Intragastric Balloon (BIB) system was developed for obese patients.
• Clinical possibilities were assessed regarding materials and application methods.

Purpose of the Study:

• To evaluate the clinical efficacy and safety of the BioEnterics Intragastric Balloon (BIB) for weight loss in obese and morbidly obese patients.
• To determine the optimal indications for BIB use in various patient populations.

Main Methods:

• 132 obese patients (143 BIB placements) underwent endoscopic insertion and removal of the BIB.
• Patients received a 800-1000 kcal/day diet with regular check-ups and dietitian consultations.
• Procedures were performed under conscious sedation or general anesthesia, with balloon removal typically at 4 months.

Main Results:

• Mean weight loss was 14.4 kg, and mean BMI reduction was 5.2.
• Weight loss was more significant in male patients.
• Observed complications included balloon intolerance (9 early removals), one deflation, and two gastric ulcers.

Conclusions:

• BIB is indicated for extremely obese patients (BMI>40) preparing for bariatric surgery.
• It is also suitable for obese patients (BMI 30-35) with unresolved chronic diseases.
• Patients with BMI<30 may benefit within a multidisciplinary approach.